Screening, Diagnosing and Managing Sexually Transmitted Infections (STIs) in 2025

Speaker:
Victor Leung, MD
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025